In preparation towards manufacturing additional quantities of the Goat Pox vaccine as well as to ensure the continuance of the manufacturing and the supply of all other vaccines against poultry, sheep, goat and cattle, Hester is undergoing capacity expansion. This capacity expansion would be completed in January 2023.

Further, ICAR-IVRI have jointly developed a Lumpy Skin Disease vaccine. As soon as the technology is made available, Hester will acquire the same and manufacture and commercialize the Lumpy Skin disease Vaccine.